Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license
Cockayne Syndrome Type 2, as genome-wide studies have reported it: 29 positions from 1 study. Built from the GWAS Catalog's records and rebuilt when a new position is reported; the figures are the studies'.
1 study in the GWAS Catalog report 29 positions for Cockayne Syndrome Type 2, which the catalogue files as "Cockayne syndrome type 2". MyGeneLog follows the condition as positions arrive: code builds this page from the records, adds each new position when it is reported, and writes no sentence of its own beyond them.
A study. The 29 positions on this page from it: rs1010201937 (ERCC6), rs1033353171 (ERCC6), rs121917900 (ERCC6), rs121917902 (ERCC6), rs1362935450 (ERCC6), rs144445150 (ERCC6), rs151242354 (ERCC6), rs1554875536 (ERCC6), and 21 more.
The 29 positions sit in or beside 1 gene: ERCC6. These are locations, as the catalogue records them; whether any of these genes is how a position acts is a question the records leave open.
Read this page as a list of findings about Cockayne Syndrome Type 2, not as an account of it. Each finding is a position that a genome-wide study linked to the condition across a population; the page adds no description, no prevalence and no advice, because the records hold none. The variant pages linked above give each study's record for its position, and ClinVar's where one exists.
Cockayne Syndrome Type 2 is diagnosed by a clinician — not from a genotype. None of the 29 variants on this page is used by any guideline to predict, screen for or diagnose it.
Everything here comes from population-level association records, put together by code. Those records compare groups of people; they do not examine anyone, and they give no guidance on care. For symptoms, testing or treatment, ask a clinician.
Databases, guidelines and references
Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license
Cockayne Syndrome Type 2. MyGeneLog™. https://www.mygenelog.com/conditions/cockayne-syndrome-type-2
Cockayne Syndrome Type 2 is the condition the GWAS Catalog files under "Cockayne syndrome type 2". This page does not define it in its own words; it lists what genome-wide studies have reported: 29 positions from 1 study, with each study's sample and citation.
Genome-wide studies have reported 29 associated positions. Each common variant has a small effect, and an association in a population is not a cause in any one person.
The positions lie in or near 1 gene: ERCC6. A mapped gene is the catalogue's location for a position, not a mechanism.
No. They are population-level findings of small effect. Cockayne Syndrome Type 2 is diagnosed by a clinician, and no guideline uses a genotype to predict it.
Free to reuse, non-commercially. This page's text is original writing from freely-available research, licensed CC BY-NC 4.0 — share and adapt it with attribution to MyGeneLog™; commercial use is licensed. It's general research-derived information, not medical advice or a diagnosis — see Terms of Use.